Navigation Links
ADHD Medications Don't Pose Cancer Risk
Date:11/21/2008

Study found 2 popular drugs do not cause genetic damage that can lead to disease

FRIDAY, Nov. 21 (HealthDay News) -- Two popular medications for treating attention-deficit hyperactivity disorder (ADHD) do not cause genetic damage linked to an increased risk for developing cancer, a new study says.

The study, done by researchers at Duke University Medical Center and the National Institutes of Health, counters a previous one that reported biomarkers associated with an increased cancer risk were present in the blood of children taking the ADHD drug methylphenidate.

"The new findings should help alleviate some of the concerns that were raised by the previous study," study co-author Scott Kollins, director of Duke's ADHD program, said in a university news release. "However, we need to continue to study the long-term effects of these medications and expand our analyses to include older patient populations."

The new study, which looked at methylphenidate (Ritalin LA and Concerta) and amphetamine (Adderall and Adderall XR), used a larger study sample and conditions that apply to a wider cross-section of children with ADHD than the initial study did, he said.

"We looked at three common markers associated with damaged chromosomes and did not find increased genetic abnormalities in children taking either medication, regardless of a variety of factors, such as age, sex, body weight, height, race or ADHD subtype," Kollins said.

About 2 million children have ADHD, a condition commonly characterized by inattention, hyperactivity and impulsivity. Methylphenidates and amphetamines have been used to treat the condition for decades, with millions of prescriptions written for them in the United States every year.

The study was published in the November online issue of the Journal of the American Academy of Child & Adolescent Psychiatry.

More information

The U.S. National Institute of Mental Health has more about ADHD.



-- Kevin McKeever



SOURCE: Duke University Medical Center, news release, Nov. 19, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New study: A Common Class of GI Medications Reduce Protection Against Heart Attack in Patients Taking Widely Prescribed Cardiovascular Drug
2. Naturally Safe Cold Remedy Challenges Effectiveness of Over-The-Counter Cold Medications
3. Triglyceride Levels Continue to Rise in the United States Despite Increased Use of Cholesterol-Lowering Medications
4. New Google Health Application Helps Users Find Patient Assistance Programs for Medications Using PatientAssistance.com
5. Anti-inflammatory medications may become a treatment for schizophrenia
6. VIDEO from Medialink and Philips: Microbubbles Developed to Administer Medications That Fight Cancer and Reduce Side Effects
7. Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications
8. Researchers examine safety of Internet prescriber service providing erectile dysfunction medications
9. Allergic-like reactions to iodinated contrast material treated safely with commonly used medications
10. Study Measures Real-World Comparative Effectiveness of Asthma Controller Medications
11. National Headache Foundation Offers Statement, Experts on Appropriate Use of Medications for Migraine Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
ADHD Medications Don't Pose Cancer Risk
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to stabilize critical ... leave patients with dental emergencies at risk of losing a tooth or their smiles. ... , Common dental emergencies include:, , Avulsed or knocked-out ...
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ... Care Association™ (ALCA) to conduct a survey that takes a closer look at cases ... illustrates the prevalence and causes of TBI among the aging population, and identifies the ...
(Date:2/10/2016)... ... 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused ... full year ended December 31, 2015 on Monday, February 29, 2016 after the market ... community following the release at 4:30 PM ET. Investors interested in participating by phone ...
(Date:2/10/2016)... ... ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves with age, ... Guide to Brain Training" by award-winning author Phyllis Strupp explains how brain ... 16, 2016. A free review copy is available to the media at NetGalley ...
(Date:2/10/2016)... ... February 10, 2016 , ... IDEX Health & ... PEEK-lined stainless steel (PLS) columns combine the strength of traditional stainless steel with ... of biological samples while operating at ultra-high pressures of 20,000 psi. The higher ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... SUNNYVALE, Calif. , Feb. 10, 2016 /PRNewswire/ ... Warren Kocmond , formerly Executive Vice President ... the position of President and Chief Operating Officer.  ... been expanded, and now include Global Commercial Operations ... and Customer Service.  Mr. Kocmond will continue to ...
(Date:2/10/2016)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), today announced ... full year ended December 31, 2015. ... year for Vanda with the continued growth of HETLIOZ ... HETLIOZ for Non-24," said Mihael H. Polymeropoulos, M.D., Vanda,s ... U.S. product portfolio builds on this success and underscores ...
(Date:2/10/2016)... LEXINGTON, Massachusetts , February 10, 2016 --> ... Japan .  --> Japan .  ... Japan .  With submission, Shire continues to ... --> With submission, Shire continues to ... With submission, Shire continues to strengthen ...
Breaking Medicine Technology: